Collagen isoform shift during the early phase of reverse left ventricular remodelling after relief of pressure overload

European Heart Journal

Volumn 32, Issue 2, 2011, Pages 236-245

  Bjørnstad, Johannes Lagethon ^a,b,c   Sjaastad, Ivar ^a,c   Nygård, Såtle ^c   Hasic, Almira ^a,c   Ahmed, Mohammad Shakil ^c,d   Attramadal, Hvard ^c,d   Finsen, Alexandra Vanessa ^c,d   Christensen, Geir ^c   Tønnessen, Theis ^a,b,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Aortic stenosis; Collagen subtypes; Extracellular matrix; GDF 15; Reverse remodelling

Indexed keywords

ANGIOTENSIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCENDING AORTA SURGERY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE OVERLOAD; LUNG WEIGHT; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DOPPLER IMAGING;

ANIMALS; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIAC OUTPUT; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; HYPERTROPHY, LEFT VENTRICULAR; LIGATION; MALE; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MYOCARDIUM; PROTEIN ISOFORMS; RNA, MESSENGER; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR REMODELING;

EID: 78651481195     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq166     Document Type: Article

References (38)

1. Weber KT, Jalil JE, Janicki JS, Pick R. Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease. Am J Hypertens 1989;2:931-940.
2. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989;79:744-755.
3. Lund O, Emmertsen K, Dorup I, Jensen FT, Flo C. Regression of left ventricular hypertrophy during 10 years after valve replacement for aortic stenosis is related to the preoperative risk profile. Eur Heart J 2003;24:1437-1446.
4. Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system. Cardiovasc Res 2006;69:15-25.
5. Fielitz J, Hein S, Mitrovic V, Pregla R, Zurbrugg HR, Warnecke C, Schaper J, Fleck E, Regitz-Zagrosek V. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 2001;37:1443-1449.
6. Tønnessen T, Giaid A, Saleh D, Naess PA, Yanagisawa M, Christensen G. Increased in vivo expression and production of endothelin-1 by porcine cardiomyocytes subjected to ischemia. Circ Res 1995;76:767-772.
7. Neverdal NO, Knudsen CW, Husebye T, Vengen ØA, Pepper J, Lie M, Tønnessen T. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis-one year follow-up. Eur J Heart Fail 2006;8:257-262.
8. Bjørnstad JL, Neverdal NO, Vengen ØA, Knudsen CW, Husebye T, Pepper J, Lie M, Christensen G, Tønnessen T. Alterations in circulating activin A, GDF-15, TGF-beta3 and MMP-2, -3, and -9 during one year of left ventricular reverse remodelling in patients operated for severe aortic stenosis. Eur J Heart Fail 2008;10:1201-1207.
9. Alexa A, Rahnenfuhrer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 2006; 22:1600-1607.
10. Fard A, Wang CY, Takuma S, Skopicki HA, Pinsky DJ, Di Tullio MR, Homma S. Noninvasive assessment and necropsy validation of changes in left ventricular mass in ascending aortic banded mice. J Am Soc Echocardiogr 2000;13:582-587.
11. Wu Z, Irizarry RA, Gentleman R, Martinez-Murillo F, Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc 2004;9:909-917.
12. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B (Stat Methodol) 1995;1:289-300.
13. Liu H, Sanuda-Pena MC, Harvey-White JD, Kalra S, Cohen SA. Determination of submicromolar concentrations of neurotransmitter amino acids by fluorescence detection using a modification of the 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate method for amino acid analysis. J Chromatogr A 1998;828:383-395.
14. Laurent GJ, Cockerill P, McAnulty RJ, Hastings JR. A simplified method for quantitation of the relative amounts of type I and type III collagen in small tissue samples. Anal Biochem 1981;113:301-312.
15. Seeland U, Haeuseler C, Hinrichs R, Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K, Bohm M. Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest 2002;32:295-303.
16. Andersson KB, Finsen AV, Sjaland C, Winer LH, Sjaastad I, Odegaard A, Louch WE,Wang Y, Chen J, Chien KR, Sejersted OM, Christensen G. Mice carrying a conditional Serca2(flox) allele for the generation of Ca(2+) handlingdeficient mouse models. Cell Calcium 2009;46:219-225.
17. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software developme.
18. Bruggink AH, van Oosterhout MF, De JN, Ivangh B, van KJ, Voorbij RH, Cleutjens JP, Gmelig-Meyling FH, De Weger RA. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant 2006;25:1091-1098.
19. Umar S, Bax JJ, Klok M, van Bommel RJ, Hessel MH, den AB, Bleeker GB, Henneman MM, Atsma DE, van der Wall EE, Schalij MJ, van der LA. Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy. Eur J Heart Fail 2008;10:878-883.
20. O'Brien M. The anatomy of the Achilles tendon. Foot Ankle Clin North Am 2005;10: 225-238.
21. Alexander JJ. The pathobiology of aortic aneurysms. J Surg Res 2004;117:163-175.
22. Hou G, Mulholland D, Gronska MA, Bendeck MP. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am J Pathol 2000;156:467-476.
23. Adiguzel E, Hou G, Mulholland D, Hopfer U, Fukai N, Olsen B, Bendeck M. Migration and growth are attenuated in vascular smooth muscle cells with type VIII collagen-null alleles. Arterioscler Thromb Vasc Biol 2006;26:56-61.
24. Cherepanova OA, Pidkovka NA, Sarmento OF, Yoshida T, Gan Q, Adiguzel E, Bendeck MP, Berliner J, Leitinger N, Owens GK. Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration. Circ Res 2009;104:609-618.
25. Iruela-Arispe ML, Sage EH. Expression of type VIII collagen during morphogenesis of the chicken and mouse heart. Dev Biol 1991;144:107-118.
26. Shuttleworth CA. Type VIII collagen. Int J Biochem Cell Biol 1997;29:1145-1148.
27. Bujak M, Frangogiannis NG. The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007;74:184-195.
28. Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J, Heineke J, Kotlarz D, Xu J, Molkentin JD, Niessen HW, Drexler H, Wollert KC. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006;98:351-360.
29. Frank D, Kuhn C, Brors B, Hanselmann C, Ludde M, Katus HA, Frey N. Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program. Hypertension 2008;51:309-318.
30. Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006;98:342-350.
31. Selander KS, Brown DA, Sequeiros GB, Hunter M, Desmond R, Parpala T, Risteli J, Breit SN, Jukkola-Vuorinen A. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases. Cancer Epidemiol Biomarkers Prev 2007;16:532-537.
32. Kuster GM, Kotlyar E, Rude MK, Siwik DA, Liao R, Colucci WS, Sam F. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation 2005;111:420-427.
33. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999;99:2694-2701.
34. Katada J, Meguro T, Saito H, Ohashi A, Anzai T, Ogawa S, Yoshikawa T. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction. Circulation 2005;111:2157-2164.
35. Gao XM, Kiriazis H, Moore XL, Feng XH, Sheppard K, Dart A, Du XJ. Regression of pressure overload-induced left ventricular hypertrophy in mice. Am J Physiol Heart Circ Physiol 2005;288:H2702-H2707.
36. Stansfield WE, Rojas M, Corn D, Willis M, Patterson C, Smyth SS, Selzman CH. Characterization of a model to independently study regression of ventricular hypertrophy. J Surg Res 2007;142:387-393.
37. Stansfield WE, Charles PC, Tang RH, Rojas M, Bhati R, Moss NC, Patterson C, Selzman CH. Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile. J Thorac Cardiovasc Surg 2009;137:232-238.
38. Walther T, Schubert A, Wustmann T, Falk V, Walther C, Doll N, Rastan A, Gummert J, Mohr FW. Reverse remodeling of cardiac collagen protein expression after surgical therapy for experimental aortic stenosis. J Heart Valve Dis 2006;15: 651-656.